Multifocal Rhizopus microsporus lung infection following brush clearing by Tsyrkunou, Artsiom V. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Infectious Diseases and Immunology 
Publications and Presentations Infectious Diseases and Immunology 
2014-08-08 
Multifocal Rhizopus microsporus lung infection following brush 
clearing 
Artsiom V. Tsyrkunou 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/infdis_pp 
 Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the 
Respiratory Tract Diseases Commons 
Repository Citation 
Tsyrkunou AV, Ellison RT, Akalin A, Wiederhold N, Sutton DA, Lindner J, Fan H, Levitz SM, Zivna I. (2014). 
Multifocal Rhizopus microsporus lung infection following brush clearing. Infectious Diseases and 
Immunology Publications and Presentations. https://doi.org/10.1016/j.mmcr.2014.08.001. Retrieved 
from https://escholarship.umassmed.edu/infdis_pp/212 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Infectious Diseases 
and Immunology Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more 
information, please contact Lisa.Palmer@umassmed.edu. 
Multifocal Rhizopus microsporus lung infection following brush clearing
Artsiom V. Tsyrkunou a,n, Richard T. Ellison IIIb,1, Ali Akalin c,2, Nathan Wiederhold d,3,
Deanna A. Sutton d,4, Jonathan Lindner d,5, Hongxin Fan d,6, Stuart M. Levitz e,7, Iva Zivna b,8
a Infectious Disease and Immunology Department, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
b UMass Memorial Medical Center – Memorial Campus, 119 Belmont Street, Worcester, MA 01605, USA
c Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
d Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
e University of Massachusetts Medical School, 364 Plantation Street, LRB 317, Worcester, MA 01605, USA
a r t i c l e i n f o
Article history:
Received 23 July 2014
Received in revised form
1 August 2014






a b s t r a c t
We report a case of pulmonary Rhizopus microsporus infection in a patient with untreated diabetes
following brush clearing. The patient was successfully treated with a combined medical and surgical
approach with complete resolution of the lung lesions and remains asymptomatic at 11-month follow-up.
& 2014 The Authors. International Society for Human and Animal Mycology. Published by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Pulmonary Rhizopus infection has only rarely been described in
immunocompetent hosts [1,2]. The major risk factor is neutropenia
in the setting of hematological malignancy. Less common risk factors
include immunosuppression to prevent transplant rejection and
uncontrolled diabetes [1,3]. In a large epidemiological study of
patients with mucormycosis infection, the predominant clinical
manifestation in diabetics was involvement of orbits and sinuses in
66% [1]. Pulmonary infection with mucormycosis was reported in
16% of patients, with most cases seen in patients with lung cancer [1].
Herein we report a very rare case of invasive pulmonary Rhizopus
microsporus infection in a patient without evidence of immunodeﬁ-
ciency, except untreated diabetes and a short course of steroids for
chronic obstructive pulmonary disease exacerbation. This case of
multifocal pneumonia due to R. microsporus infection was likely
linked to environmental exposure during brush clearing of dead
leaves, glass, and branches of the fallen trees. Our case report
emphasizes the importance of considering fungal infections in
patients with very common diseases, such as chronic obstructive
pulmonary disease and poorly controlled diabetes mellitus in the
setting of environmental exposure to organic matter.
2. Case
A 61-year-old man presenting to the hospital (day 0) with
progressive shortness of breath and a productive cough for 3 weeks
was found to have multiple new bilateral nodular and cavitary
lesions in his lungs. On day –18 he had been seen at a local
Emergency Department with a history of several days of cough,
and at that time had had a chest X-ray, showed only hyperinﬂa-
tion. He was diagnosed with a chronic obstructive pulmonary
disease (COPD) exacerbation and received intravenous corticoster-
oids, followed by an oral taper. Azithromycin dose pack was
prescribed for 5 days and the patient was sent home. Despite
a course of steroids and azithromycin, he experienced worsening
of his cough and noted moderate amounts of yellow phlegm along
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with progressive worsening of shortness of breath. He also
reported a new onset of left-sided pleuritic chest pain.
His past medical history was signiﬁcant for a 40 pack-year
history of smoking, untreated diabetes mellitus type II, and
occasional alcohol use. The patient was born in the United States
and denied international travel. He lived with his wife in a rural
area in the Central Massachusetts and spent much of his spare
time clearing trees from multiple acres of wooded land that
he owned.
On examination, he had mildly elevated temperature of 37.7 1C;
otherwise, he had stable vital signs with an oxygen saturation
of 94% on room air. There was no tenderness over his sinuses;
no conjunctivitis or tenderness of the abdomen. Examination of
mucosa in the mouth and nasopharynx did not show purulent
discharge, erythema, or necrotic changes. Auscultation of the lungs
was signiﬁcant for bilateral crackles. Laboratory studies showed
a total white count of 13,200 per mm3 with 78% neutrophils. His
blood glucose level was elevated to 257 mg/dL and the bicarbonate
level was 28 mmol/L. On hospital day þ1 a chest computed
tomography (CT) scan showed multifocal pneumonia with central
cavitation (Fig. 1). There was a trace left pleural effusion. Border-
line enlarged bilateral hilar, lower paratracheal, subcarinal, and
periaortic lymph nodes were present.
He was started on treatment with intravenous vancomycin and
piperacillin-tazobactam. His sputum cultures showed normal
respiratory ﬂora and blood cultures performed prior to antibiotics
remained negative after 5 days of incubation. Results of human
immunodeﬁciency virus antibodies, anti-neutrophil antibodies,
serum Aspergillus galactomannan and serum beta-D-glucan tests
were negative. On hospital day þ4 the patient underwent
bronchoscopy which showed minimal secretions and no endo-
bronchial lesions. Rare fungal hyphae were seen on microscopy of
bronchoalveolar lavage specimens. Empiric liposomal amphoter-
icin B at a dose of 5 mg/kg per day was initiated on day þ8. A ﬁne
needle aspiration of the lung lesion adjacent to the chest wall was
performed and subsequently on hospital day þ15 the patient
underwent open thoracotomy with left upper lobe resection.
It was not possible to resect all the cavitary lesions due to the
wide distribution of the lesions throughout both lungs.
All microbiological samples from induced sputum, bronchoal-
veolar lavage and lung tissue grew a Rhizopus sp. Further char-
acterization of the fungus was performed by the Fungus Testing
Laboratory at the University of Texas Health Science Center at San
Antonio. Macroscopic and microscopic features were noted on
a potato ﬂakes agar (PFA) plate and a water agar plate, respec-
tively, incubated at 25 1C for 7 days. Colonies were Light Gull Gray
to Gull Gray to Mouse Gray centrally [4] and woolly with a short
nap (Fig. 2A). Some subcultures, however, demonstrated some-
what taller growth. Microscopic features included ramiﬁed nodal
rhizoids, short (less than 500 mm) pale to medium brown spor-
angiophores, pyriform to ellipsoidal-shaped columella (Fig. 2B and
C), and pale brown, subglobose to slightly angular sporangiospores
(approximately 4 mm in diameter), lacking noticeable striations
(Fig. 2D). Numerous intercalary chlamydospores were also present.
Luxurious growth was noted at 37 1C, 40 1C, and 45 1C; reduced
growth occurred at 50 1C.
Molecular identiﬁcation was consistent with Rhizopus
microsporus in clinical samples. Template DNA was prepared by
subculturing the isolate onto PFA and incubating at 30 1C. Hyphal
elements were scraped from the agar surface and suspended in
CPL-100 Buffer (VWR International INC, Radnor, PA). The specimen
was then lysed by bead beating, and DNAwas isolated manually by
the chloroform extraction method. Extracted DNA was used for
PCR ampliﬁcation of ITS and D1/D2 regions as described with
slight modiﬁcation [5]. PCR products were then sequenced using
the ITS1 and ITS4 primers as well as NL1 and NL4 primers at the
UTHSCSA Molecular Diagnostics Laboratory [6]. Sequences were
assembled and analyzed using DNASTAR software (DNASTAR, Inc.,
Madison, WI) and queried in GenBank using the BLASTn algorithm
at the NCBI site (www.ncbi.nlm.nih.gov). Sequences were also
compared to those available in the CBS-KNAW Fungal Biodiversity
Centre database (www.cbs.knaw.nl). The ITS sequence demon-
strated 100% identity to R. microsporus (GenBank Accession No.
JN561253.1; base pair match 696/696), and the D1/D2 sequence
also showed 100% identity to R. microsporus (CBS Accession No.
343.29; base pair match 699/699). The ITS and D1/D2 nucleotide
sequences of the isolate were deposited into GenBank under
accession numbers KM103772 and KM103773, respectively. The
isolate (UTHSCSA DI 14-206) has been deposited into the Uni-
versity of Alberta Microfungus Collection and Herbarium under
UAMH accession number 11833.
Pathological examination of the resected left upper lung lobe
revealed a lung abscess with an internal surface showing necrosis,
abundant mixed inﬂammatory cells, nuclear debris and the pre-
sence of broad, empty-looking fungal hyphae consistent with
Rhizopus (Fig. 3). The wall of the abscess cavity and surrounding
Fig. 1. A. CT scan (with intravenous contrast) image of upper lobes of the lungs demonstrating an extensive area of consolidation of the apical-posterior segment of the left
upper lobe with a large area of central cavitation. B. CT scan image of the lower lobes of the lungs showing numerous smaller foci of consolidation throughout the lungs
bilaterally (18 nodular lesions in both lungs), some with central necrosis and some with central cavitation.
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lung parenchyma also revealed some granulomas as well as
evidence of organizing pneumonia with features of acute ﬁbrinous
and organizing pneumonia (AFOP). No vasculitis was seen. Addi-
tional screening studies for disseminated fungal infection were
negative for lesions in the brain and sinuses.
Antifungal susceptibility testing was performed at ARUP
Laboratories, Salt Lake City, Utah, according to the CLSI M38-A2
methods [7]. The minimal inhibitory concentrations (MIC) were
2 μg/mL for amphotericin, 2 μg/mL for itraconazole, and 1 μg/mL
for posaconazole.
After recovery from the lung surgery on hospital day þ22, the
patient was started on posaconazole oral suspension, 200 mg four
times a day. After 1 week of treatment with posaconazole, serum
concentrations were 1.4 μg/mL. Subsequent levels were 1.6 μg/mL
and 2.1 μg/mL. Liposomal amphotericin B was stopped on day
þ30 and patient was discharged home on day þ32 on posacona-
zole treatment. He was also begun on anti-diabetic medications
with diet modiﬁcation and tight glucose control. After 8 weeks of
therapy, a repeat CT scan of the chest showed marked improve-
ment in the size and number of lung opacities. Posaconazole
therapy was stopped after ﬁnishing a 12-week course. His hemo-
globin A1c decreased from 14.7% on his initial presentation to 7.3%
at the end of therapy. Subsequent chest X-ray performed 4 weeks
after he ﬁnished posaconazole showed complete resolution of the
inﬁltrates in the lungs. The patient remains asymptomatic at
11-month follow-up.
3. Discussion
Members of the Order Mucorales are ubiquitous in the envir-
onment and can be found on decaying organic material and soil
[8]. They are characterized by broad irregularly-branched hyphae
with rare septations [9,10]. Members of the R. microsporus group
were previously separated into several varieties based upon
different morphologic characteristics, and included R. microsporus
var. microsporus, R. microsporus var. rhizopodiformis, R. microsporus
var. chinensis, R. microsporus var. azygosporus, R. microsporus var.
oligosporus, and R. microsporus var. tuberosus [11]. However, a
recent study that evaluated 48 isolates of different varieties
demonstrated that despite variable phenotypic features the iso-
lates were identical by sequence analysis and therefore should be
reported under the name R. microsporus without assignment of
a varietal status [12].
It has been shown that airborne spores of Rhizopus microsporus
are frequently found in ﬁlter samples of wood trimmers [13].
There was also a correlation found between the level of exposure
to mold spores and the level of speciﬁc immunoglobulin G to
R. microsporus and Paecilomyces variotii in newly employed wood
trimmers and those who had already worked in the trimming
department [13]. No cases of infection due to R. microsporus were
reported in that study. However, in another study from Norway,
the mean level of speciﬁc immunoglobulin G antibodies to
R. microsporus in sawmill workers was the best predictor of
Fig. 2. A. Potato ﬂakes agar plate (60 mm) after 7 days incubation at 25 1C, demonstrating a gray, woolly colony with a ﬂat nap; B. Two short, pale brown sporangiophores
arising from nodal rhizoids; one sporangium is intact containing sporangiospores, while the other demonstrates a pyriform ellipsoid-shaped columella; C. Nodal rhizoids,
short, brown sporangiophores and sporangia; D. Subglobose and slightly angular sporangiospores lacking noticeable striations. Mounting medium 85% lactic acid, B and D;
lactophenol cotton blue, C. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. A. Left lung upper lobe abscess cavity with necrotic lung tissue, abundant mixed acute and chronic inﬂammatory cells and nuclear debris (H&E stain, 100 ).
B. Periodic acid Schiff (PAS) stain demonstrated numerous wide, ribbon-like, thin-walled hyphae with folding and twisting. The hyphae revealed irregular branching and rare
septation (pauciseptate). There were abundant admixed neutrophils and nuclear debris (PAS fungal stain, 400 ).
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respiratory symptoms, such as mucous membrane irritation,
chronic nonspeciﬁc lung disease, allergic alveolitis, and organic
dust toxic syndrome. This suggests that exposure to spores from
Rhizopus microsporus may cause several types of respiratory
symptoms in wood trimmers [14].
The clinical picture of pulmonary Rhizopus infection is non-
speciﬁc. Patients frequently have fever, cough, shortness of breath,
weight loss, and hemoptysis, which may suggest the presence of
invasive fungal infection [2]. Chest radiographs show involvement
of the upper part of the chest in nearly half of the patients [2]. The
multiple lesions in both lungs noted in our patient could have
been a result of the inhalation of a large number of spores as he
was engaged in tree work although a contribution from endo-
bronchial spread should also be considered.
Diagnostic evaluation for Rhizopus infection frequently requires
an invasive procedure to obtain tissue samples. Treatment of
pulmonary Rhizopus infection is complex and often managed by
multiple specialists. It is important to consider surgical debride-
ment or resection early in the disease course as the outcome in
patients treated with a combined medical and surgical approach
tends to be better [1,15]. Medical management includes an
induction phase until clinical and radiographic response and
subsequent consolidation therapy until the resolution of the
symptoms and clearance of radiographic changes [16]. Most
authors recommend continuing therapy until clinical resolution
of signs and symptoms of infection and improvement in imaging
studies as was done in our patient [16,17].
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